Merck pulls plug on Alzheimer's drug because of li
Post# of 1458
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Behind a paywall.
Quote:
Merck has ended work on two separate Phase II studies of its small molecule for treatment-resistant depression and mild-to-moderate Alzheimer’s disease, the pharma confirmed to Endpoints News.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)